Physician profile
Grace M Hecker
NPI 1043659337
$1,330.11
in general payments reported to CMS, 2019-2025
15 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.99 · 2020: $347 · 2021: $235 · 2022: $132 · 2023: $265 · 2024: $45.74 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $334.70 | 2022-2025 | |
| Novo Nordisk INC | $298.83 | 2019-2022 | |
| Lilly USA, LLC | $127.41 | 2020-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $110.62 | 2019-2025 | |
| Corcept Therapeutics | $107.42 | 2021-2025 | Korlym |
| Allergan, INC. | $100.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.23 | 2019-2021 | |
| Eisai INC. | $54.04 | 2020-2021 | |
| Glaxosmithkline, LLC. | $30.23 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $23.45 | 2021 | |
| Xeris Pharmaceuticals, INC. | $22.25 | 2025 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $18.87 | 2022 | |
| Almatica Pharma LLC | $17.04 | 2024 | Loreev Xr |
| Currax Pharmaceuticals LLC | $14.70 | 2025 | Contrave |
| Amgen INC. | $14.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Hecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.